- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.02. | Ikonisys SA: Ikonisys: Hospitex International to Partner With Allianz Value for First Large-Scale Screening Program Dedicated to Urinary Tract Oncology Diagnostics in Italy | 337 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 19.02. | Ikonisys SA: Ikonisys Announces That Hospitex International Won the Public Tender of the Prestigious U.O.C. Pathological Anatomy of Ragusa | 292 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 06.02. | Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy | 173 | dpa-AFX | Original-Research: Ikonisys SA - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu Ikonisys SA Unternehmen: Ikonisys SA ISIN: FR00140048X2 Anlass der Studie: Update Report Empfehlung:... ► Artikel lesen | |
| 02.01. | Ikonisys SA: Ikonisys: New Production Record for Hospitex International | 399 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 28.12.23 | Ikonisys Announces the Completion of a Private Placement to Speed up Growth Following Recent Pivotal Deals | 528 | Business Wire | Private placement of €1m, conducted with a restricted group of Italian private and institutional investors Following recent announcements, these funds will enable Ikonisys to speed up growth... ► Artikel lesen | |
| 15.12.23 | Ikonisys SA: Ikonisys Announces a Partnership Between Hospitex International and the Pathologists Beyond Borders Association | 299 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 30.11.23 | Ikonisys SA: Ikonisys to Acquire Hospitex International and Become an Integrated Cancer Diagnostic Leader | 353 | Business Wire | Hospitex, a world leader in Thin Layer Cytology and Cancer Diagnostics, providing a competitive solution based on a patented and cutting-edge technology, the Nephelometric Smart Technology (NST)... ► Artikel lesen | |
| 01.11.23 | Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy | 291 | dpa-AFX | Original-Research: Ikonisys SA - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu Ikonisys SA Unternehmen: Ikonisys SA ISIN: FR00140048X2 Anlass der Studie: Update Report Empfehlung:... ► Artikel lesen | |
| 31.10.23 | Ikonisys SA: Ikonisys and Biocare Medical Forge Alliance: Amplifying Global FISH Diagnostics with Advanced Fluorescent Scopes | 342 | Business Wire | Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Ticker: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical diagnostic... ► Artikel lesen | |
| 30.10.23 | Ikonisys SA: Ikonisys publishes its 2023 half-year financial results and reviews its operational and strategic deployments | 278 | Business Wire | Expansion of the market outside of the US and Europe and beginning of the commercialization of the high-volume system, Ikoniscope20max:
Signing of a Distribution Collaboration with Integrated... ► Artikel lesen | |
| 16.10.23 | Ikonisys Successfully Completed Its ISO Certification Reaffirming Its Ability to Continuously Meet Quality International Standard Requirements | 319 | Business Wire | Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Ticker: ALIKO) (Paris:ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution... ► Artikel lesen | |
| 10.10.23 | Ikonisys SA: Successful Study in Collaboration With the Neag Cancer Center of UConn School of Medicine Demonstrates the Power of the Ikoniscope Platform for Detection of Extremely Rare Cells in the Field of Immuno-Oncology | 375 | Business Wire | Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Ticker: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical diagnostic... ► Artikel lesen | |
| 03.08.23 | Ikonisys Announces the Completion of New Financing via the Issuance of a €0.5m Private Note | 514 | Business Wire | Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical... ► Artikel lesen | |
| 31.07.23 | Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy | 3.041 | dpa-AFX | Original-Research: Ikonisys SA - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu Ikonisys SA Unternehmen: Ikonisys SA ISIN: FR00140048X2 Anlass der Studie: Update Report Empfehlung:... ► Artikel lesen | |
| 31.07.23 | Ikonisys SA: Ikonisys presents an update of its global activity in the context of its recent technological and commercial milestones | 366 | Business Wire | Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical... ► Artikel lesen | |
| 28.07.23 | Ikonisys SA: Ikonisys Announces the Successful Deployment of the Commercial Strategy With the Second Sale of the Ikoniscope20max Solution | 709 | Business Wire | Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution for medical... ► Artikel lesen | |
| 26.07.23 | Ikonisys SA: Half-Yearly Report on the Ikonisys Liquidity Contract at 30/06/2023 | 421 | Business Wire | Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO
For the liquidity contract signed by Ikonisys with Invest Securities, the following means were included in the liquidity... ► Artikel lesen | |
| 30.06.23 | Ikonisys SA: Ikonisys Announces the Results of Its Ordinary Annual and Extraordinary General Meeting of June 28, 2023 | 556 | Business Wire | Adoption of all resolutions submitted to the vote
Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO), a company specializing in the early and accurate detection of cancer... ► Artikel lesen | |
| 21.06.23 | Ikonisys SA: Ikonisys Announces the First Sale of the Ikoniscope20max Solution | 392 | Business Wire | Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO) (Paris:ALIKO), a company specializing in the early and accurate detection of cancer with a unique fully-automated solution... ► Artikel lesen | |
| 15.06.23 | Ikonisys SA: Ikonisys Announces the Completion of a Private Placement to Accelerate Its Commercial Development | 434 | Business Wire | Private placement of €0.5m, conducted with a restricted group of Italian investors and Cambria Equity Partners
Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Mnemonic: ALIKO), a... ► Artikel lesen |
Seite:
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 52,76 | +1,15 % | Dividendenbekanntmachungen (19.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABG SUNDAL COLLIER HOLDING ASA NO0003021909 0,5 NOK 0,0425 EUR ALM BRAND A/S DK0015250344 0,55 DKK 0,0737 EUR APA CORPORATION US03743Q1085 0... ► Artikel lesen | |
| FRESENIUS | 27,320 | -1,23 % | JPMORGAN stuft Fresenius SE auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Fresenius auf "Neutral" mit einem Kursziel von 32,50 Euro belassen. Die am 8. Mai anstehenden Quartalszahlen sollten einen ordentlichen Jahresstart... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 100,40 | -2,14 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Carl Zeiss Meditec vor Zahlen für das zweite Geschäftsquartal auf "Underweight" mit einem Kursziel von 70 Euro belassen. Seine... ► Artikel lesen | |
| MOBILE-HEALTH NETWORK SOLUTIONS | 23,880 | 0,00 % | APAC Telehealth Leader MNDR Expects Revenue Growth in H12024 vs H12023 | SINGAPORE, April 22, 2024 (GLOBE NEWSWIRE) -- Mobile-health Network Solutions (Nasdaq: MNDR) ("Mobile-Health" or the "Company"), a pioneering Asia-Pacific ("APAC") telehealth provider, today provided... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,960 | -2,36 % | Fresenius Medical Care: Was war das denn gestern? | Mit einem Kursanstieg um satte 6,44 Prozent wurde Fresenius Medical Care am Montag klarer Tagessieger im MDAX. Aber was war da los, was trieb die Aktie so stark? Vorab-Ergebnisse zum ersten Quartal... ► Artikel lesen | |
| GERRESHEIMER | 101,40 | -0,59 % | Gerresheimer wieder dreistellig - Jefferies hebt den Daumen | Zum Wochenauftakt geht es für die Gerresheimer-Aktie um zwei Prozent nach oben. Nach einem leichtem Rücksetzer notieren die Scheine damit wieder über 100 Euro. Grund für den Aufschlag ist ein positiver... ► Artikel lesen | |
| PROGYNY | 32,600 | +0,62 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,170 | -3,35 % | Where Privia Health Gr Stands With Analysts | ||
| PROCEPT BIOROBOTICS | 52,48 | -2,36 % | PROCEPT BioRobotics Corp - 8-K, Current Report | ||
| ATRICURE | 23,050 | -0,52 % | AtriCure upgraded at Oppenheimer on valuation | ||
| RXSIGHT | 52,84 | -3,79 % | RxSight, Inc. - 8-K, Current Report | ||
| ECKERT & ZIEGLER | 36,500 | -2,20 % | Eckert & Ziegler: Kurssprung nach Vorab-Zahlen … was ist das wert? | Am Montagnachmittag wartete der Strahlentechnik-Spezialist Eckert & Ziegler mit vorläufigen Ergebnissen zum 1. Quartal auf. Die Aktie machte einen Satz nach oben ... wie lässt sich das charttechnisch... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 10,780 | 0,00 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Recent Acquisitions That Continue to Drive Growth and Value | LOUISVILLE, Ky., March 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or "BrightSpring Health Services") (NASDAQ: BTSG), a leading provider of home and community-based... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 6,170 | +0,98 % | LifeStance Health Group, Inc.: LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024 | ||
| ADAPTHEALTH | 9,780 | -0,31 % | Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank |
Das Unternehmen IKONISYS kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,74 % bei einem Aktienkurs von 1,360 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
